Related content

Anakinra in mutation-negative CINCA syndrome

By Callejas José Luis   Oliver Javier   Martín Javier   Ortego Norberto  

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 576-577

Springer Publishing Company

Access to resources Recommend Favorite

A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab

By Hirano Toru  

Modern Rheumatology, Vol. 22, Iss. 2, 2012-04 ,pp. : 298-302

Springer Publishing Company

Access to resources Recommend Favorite

Good response to IL-1β blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies

By Hedrich C. M.   Fiebig B.   Sallmann S.   Bruck N.   Hahn G.   Roesler J.   Roesen-Wolff A.   Heubner G.   Gahr M.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 5, 2008-01 ,pp. : 385-389

Informa Healthcare

Access to resources Recommend Favorite

Anti-Interleukin-5 Monoclonal Antibodies: Preclinical and Clinical Evidence in Asthma Models

By Leckie M.J.  

American Journal of Respiratory Medicine, Vol. 2, Iss. 3, 2003-01 ,pp. : 245-259

Adis International

Access to resources Recommend Favorite

Beneficial Effect of Anti-Interleukin-33 on the Murine Model of Allergic Inflammation of the Lower Airway

By Kim Young Hyo   Park Chang-Shin   Lim Dae Hyun   Ahn Sung-Hye   Son Byong Kwan   Kim Jeong Hee   Jang Tae Young  

Journal of Asthma, Vol. 49, Iss. 7, 2012-09 ,pp. : 738-743

Informa Healthcare

Access to resources Recommend Favorite